Replies to post #11264 on Synaptogenix Inc (SNPX)

[Investor2014]

So it really is only a handful of iHub posters who have seen the light and are sitting on risk/reward ratio stock with as good as guaranteed multiples in return.

I rate Anavex with a 30% chance of confirming the P2a data, which many will say is too high and a few will claim is way too low.

In AD, out all indications possible, a 98.8% chance of treating patients with clinically meaningful results above SOC really does seem too good to be true.

If that truly is the objectively correct way of viewing the data, I will claim that others would have seen it and acted.

If the share price rises and is sustained much higher over the next few months up to readout, I might start believing the odds are better than I think right now...